Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics. 2007

José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
Center for Statistics, Hasselt University, Agoralaan Gebouw D, Diepenbeek, Belgium. jose.cortinas@uhasselt.be

Creutzfeldt-Jakob disease (CJD) is a rare and fatal neurodegenerative disease of unknown cause. Patients are usually aged between 50 and 75 and typical clinical features include rapidly progressive dementia associated with myoclonus and a characteristic electroencephalographic pattern. Neuropathological examination reveals cortical spongiform change, hence the term 'spongiform encephalopathy'. Several statistical techniques were applied to classify patients with sporadic CJD (sCJD), based on clinical and neuropathological investigation. We focus on the classification of neuropathologically confirmed sCJD patients. In order to obtain a classification rule that correctly classifies this type of patients and at the same time controls the overall error rate, we apply several classification techniques, which in general, produce comparable results. The boosting method produces the best results and the variable 14-3-3 protein in cerebrospinal fluid plays the most important role in the prediction of neuropathologically confirmed sCJD.

UI MeSH Term Description Entries
D007562 Creutzfeldt-Jakob Syndrome A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27)) New Variant Creutzfeldt-Jakob Disease,Spongiform Encephalopathy, Subacute,CJD (Creutzfeldt-Jakob Disease),Creutzfeldt Jacob Disease,Creutzfeldt-Jakob Disease,Creutzfeldt-Jakob Disease, Familial,Creutzfeldt-Jakob Disease, New Variant,Creutzfeldt-Jakob Disease, Variant,Familial Creutzfeldt-Jakob Disease,Jakob-Creutzfeldt Disease,Jakob-Creutzfeldt Syndrome,V-CJD (Variant-Creutzfeldt-Jakob Disease),Variant Creutzfeldt-Jakob Disease,CJD (Creutzfeldt Jakob Disease),Creutzfeldt Jakob Disease,Creutzfeldt Jakob Disease, Familial,Creutzfeldt Jakob Disease, New Variant,Creutzfeldt Jakob Disease, Variant,Creutzfeldt Jakob Syndrome,Creutzfeldt-Jakob Diseases, Familial,Disease, Creutzfeldt Jacob,Disease, Creutzfeldt-Jakob,Disease, Familial Creutzfeldt-Jakob,Disease, Jakob-Creutzfeldt,Encephalopathies, Subacute Spongiform,Encephalopathy, Subacute Spongiform,Familial Creutzfeldt Jakob Disease,Familial Creutzfeldt-Jakob Diseases,Jacob Disease, Creutzfeldt,Jakob Creutzfeldt Disease,Jakob Creutzfeldt Syndrome,New Variant Creutzfeldt Jakob Disease,Spongiform Encephalopathies, Subacute,Subacute Spongiform Encephalopathies,Subacute Spongiform Encephalopathy,Syndrome, Creutzfeldt-Jakob,Syndrome, Jakob-Creutzfeldt,V CJD (Variant Creutzfeldt Jakob Disease),Variant Creutzfeldt Jakob Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
February 1998, Neuroradiology,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
September 2006, Brain : a journal of neurology,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
June 2003, Brain : a journal of neurology,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
June 1993, Acta neurologica Scandinavica,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
January 1999, Neurologia i neurochirurgia polska,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
May 2003, Archives of neurology,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
February 2022, The American journal of emergency medicine,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
January 2016, Neurology India,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
January 2018, Handbook of clinical neurology,
José Cortiñas Abrahantes, and Marc Aerts, and Bart van Everbroeck, and Claude Saegerman, and Dirk Berkvens, and Helena Geys, and Koen Mintiens, and Stefan Roels, and Patrick Cras
September 1994, Neuroscience letters,
Copied contents to your clipboard!